It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 | Hyderabad, Telangana, India | Converted to LLPRegius Pharma Private Limited, a converted to llp private limited company, was established on 05 November 2020 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230TG2020PTC145600. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Kiran Kumar Nalamothu (Director), Vijayalakshmi Nalamothu (Director). Its latest AGM occurred on 23 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No:1-98/V/103,Flat No.103,Plot No.17&18,Vishnu Avenues, Krithika Layout, Madhapur,, Hyderabad, Telangana, 500081.
U24230TG2020PTC145600
145600
05 November 2020
₹1.00 M
₹0.20 M
Roc Hyderabad
Unlisted
Converted to LLP
Explore comprehensive insights into Regius Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Kumar Nalamothu | Director | 05 Nov 2020 | Current |
| Vijayalakshmi Nalamothu | Director | 05 Nov 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Regius Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 11060.57% decrease in profit. The company's net worth Soared by an impressive increase of 99445.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Regius Pharma had a public holding of 30.63%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Regius Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Regius Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regius Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Regius Pharma Private Limited last Annual general meeting of members was held on 23 Sep 2024 as per latest MCA records. was completed.
Progress on Regius Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Kiran Kumar Nalamothu was appointed as a Director was appointed as a Director on 05 Nov 2020 & has been associated with this company since 5 years 27 days . was recorded as a recent event.
Progress on Vijayalakshmi Nalamothu was appointed as a Director was appointed as a Director on 05 Nov 2020 & has been associated with this company since 5 years 27 days . was documented.
Regius Pharma Private Limited was registered on 05 Nov 2020 with Roc Hyderabad & aged 5 years 27 days as per MCA records. was recorded as a recent event.
The CIN of Regius Pharma Private Limited is U24230TG2020PTC145600.
Regius Pharma Private Limited is headquartered at H.No:1-98/V/103,Flat No.103,Plot No.17&18,Vishnu Avenues, Krithika Layout, Madhapur,, Hyderabad, Telangana, 500081.
Regius Pharma Private Limited was incorporated on 05 November 2020.
The current directors of Regius Pharma Private Limited are
The primary industry of Regius Pharma Private Limited is Manufacturing.
Regius Pharma Private Limited is unlisted.
The authorized capital of Regius Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Regius Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX